BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30974974)

  • 1. Cardiac troponins predict adverse clinical outcomes in stable coronary artery disease: a dose-response meta-analysis of prospective studies.
    Li Y; Pei H; Zhou C
    Biomarkers; 2019 Sep; 24(6):556-565. PubMed ID: 30974974
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognosis in relation to high-sensitivity cardiac troponin T levels in patients with myocardial infarction and non-obstructive coronary arteries.
    Hjort M; Lindahl B; Baron T; Jernberg T; Tornvall P; Eggers KM
    Am Heart J; 2018 Jun; 200():60-66. PubMed ID: 29898850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide.
    Lyngbæk S; Winkel P; Gøtze JP; Kastrup J; Gluud C; Kolmos HJ; Kjøller E; Jensen GB; Hansen JF; Hildebrandt P; Hilden J;
    Eur J Prev Cardiol; 2014 Oct; 21(10):1275-84. PubMed ID: 23723326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of elevated plasma renin activity at baseline to cardiac events in patients with angiographically proven coronary artery disease.
    Muhlestein JB; May HT; Bair TL; Prescott MF; Horne BD; White R; Anderson JL
    Am J Cardiol; 2010 Sep; 106(6):764-9. PubMed ID: 20816114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease.
    Ramchand J; Patel SK; Srivastava PM; Farouque O; Burrell LM
    PLoS One; 2018; 13(6):e0198144. PubMed ID: 29897923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preprocedural High-Sensitivity Cardiac Troponin T and Clinical Outcomes in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention.
    Zanchin T; Räber L; Koskinas KC; Piccolo R; Jüni P; Pilgrim T; Stortecky S; Khattab AA; Wenaweser P; Bloechlinger S; Moschovitis A; Frenk A; Moro C; Meier B; Fiedler GM; Heg D; Windecker S
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27296200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative.
    von Lueder TG; Girerd N; Atar D; Agewall S; Lamiral Z; Kanbay M; Pitt B; Dickstein K; Zannad F; Rossignol P;
    Eur J Heart Fail; 2015 Nov; 17(11):1144-51. PubMed ID: 26424212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: A meta-analysis.
    Liu N; Hang T; Gao X; Yang W; Kong W; Lou Q; Yang J
    PLoS One; 2020; 15(9):e0238775. PubMed ID: 32886697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troponin rise in hospitalized patients with nonacute coronary syndrome: retrospective assessment of outcomes and predictors.
    Dhesi S; Shanks M; Tymchak WJ
    Can J Cardiol; 2015 Mar; 31(3):296-301. PubMed ID: 25746021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive cardiac troponins and N-terminal pro-B-type natriuretic peptide in stable coronary artery disease: correlation with left ventricular function as assessed by myocardial strain.
    Smedsrud MK; Gravning J; Omland T; Eek C; Mørkrid L; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Edvardsen T
    Int J Cardiovasc Imaging; 2015 Jun; 31(5):967-73. PubMed ID: 25788439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen and Neopterin Is Associated with Future Myocardial Infarction and Total Mortality in Patients with Stable Coronary Artery Disease.
    Mjelva ØR; Svingen GFT; Pedersen EKR; Seifert R; Kvaløy JT; Midttun Ø; Ueland PM; Nordrehaug JE; Nygård O; Nilsen DWT
    Thromb Haemost; 2018 Apr; 118(4):778-790. PubMed ID: 29458232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PR interval prolongation in coronary patients or risk equivalent: excess risk of ischemic stroke and vascular pathophysiological insights.
    Chan YH; Hai JJ; Lau KK; Li SW; Lau CP; Siu CW; Yiu KH; Tse HF
    BMC Cardiovasc Disord; 2017 Aug; 17(1):233. PubMed ID: 28836952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Sensitivity Troponins and Outcomes After Myocardial Infarction.
    Odqvist M; Andersson PO; Tygesen H; Eggers KM; Holzmann MJ
    J Am Coll Cardiol; 2018 Jun; 71(23):2616-2624. PubMed ID: 29880121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting myocardial infarction and other serious cardiac outcomes using high-sensitivity cardiac troponin T in a high-risk stable population.
    McQueen MJ; Kavsak PA; Xu L; Shestakovska O; Yusuf S
    Clin Biochem; 2013 Jan; 46(1-2):5-9. PubMed ID: 23063983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of elevated high-sensitivity cardiac troponin T levels in a low risk outpatient population with cardiovascular disease.
    Biener M; Giannitsis E; Lamerz J; Mueller-Hennessen M; Vafaie M; Katus HA
    Eur Heart J Acute Cardiovasc Care; 2016 Oct; 5(6):409-418. PubMed ID: 26450785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of high sensitivity cardiac troponin T in patients with congenital heart disease.
    Abiko M; Inai K; Shimada E; Asagai S; Nakanishi T
    J Cardiol; 2018 Apr; 71(4):389-393. PubMed ID: 29108668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High sensitivity troponin in cardiovascular disease. Is there more than a marker of myocardial death?
    Tsounis D; Deftereos S; Bouras G; Giannopoulos G; Anatoliotakis N; Raisakis K; Kossyvakis C; Cleman MW
    Curr Top Med Chem; 2013; 13(2):201-15. PubMed ID: 23470078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting.
    Vranckx P; Farooq V; Garg S; Van Es GA; Silber S; Windecker S; Stone GW; Serruys PW
    Heart; 2012 Oct; 98(19):1424-30. PubMed ID: 22821273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of heart failure and adverse cardiovascular events in outpatients with coronary artery disease using mitral E/A ratio in conjunction with e-wave deceleration time: the heart and soul study.
    Mishra RK; Devereux RB; Cohen BE; Whooley MA; Schiller NB
    J Am Soc Echocardiogr; 2011 Oct; 24(10):1134-40. PubMed ID: 21764551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sensitivity troponin as a predictor of cardiac events and mortality in the stable dialysis population.
    Hassan HC; Howlin K; Jefferys A; Spicer ST; Aravindan AN; Suryanarayanan G; Hall BM; Cleland BD; Wong JK; Suranyi MG; Makris A
    Clin Chem; 2014 Feb; 60(2):389-98. PubMed ID: 24185551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.